Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Smid

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Journal of Hospital Infection|November 22, 2022
The effect of an intervention bundle to prevent central venous catheter-related bloodstream infection in a national programme in the NetherlandsT I I van der Kooi, E A Smid, M B G Koek, et al.
The Journal of Hospital Infection|October 19, 2019
Trends in prevalence of healthcare-associated infections and antimicrobial use in hospitals in the Netherlands: 10 years of national point-prevalence surveysT E M Hopmans, E A Smid, J C Wille, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
The activity of raltitrexed (Tomudex) in malignant pleural mesothelioma: an EORTC phase II study (08992)P Baas, A Ardizzoni, F Grossi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2003
Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958)M E R O'Brien, T Splinter, E F Smit, et al.
Clinical Pharmacology and Therapeutics|October 23, 2016
Polymorphic variation in TPMT is the principal determinant of TPMT phenotype: A meta-analysis of three genome-wide association studiesR Tamm, R Mägi, R Tremmel, et al.
Radiology|February 13, 2001
Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation ratesR J Jackman, F Burbank, S H Parker, et al.
Pharmacological Research|January 5, 2010
Enabling individualized therapy through nanotechnologyJason H Sakamoto, Anne L van de Ven, Biana Godin, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Journal of Hospital Infection|November 22, 2022
The effect of an intervention bundle to prevent central venous catheter-related bloodstream infection in a national programme in the NetherlandsT I I van der Kooi, E A Smid, M B G Koek, et al.
The Journal of Hospital Infection|October 19, 2019
Trends in prevalence of healthcare-associated infections and antimicrobial use in hospitals in the Netherlands: 10 years of national point-prevalence surveysT E M Hopmans, E A Smid, J C Wille, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
The activity of raltitrexed (Tomudex) in malignant pleural mesothelioma: an EORTC phase II study (08992)P Baas, A Ardizzoni, F Grossi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2003
Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958)M E R O'Brien, T Splinter, E F Smit, et al.
Clinical Pharmacology and Therapeutics|October 23, 2016
Polymorphic variation in TPMT is the principal determinant of TPMT phenotype: A meta-analysis of three genome-wide association studiesR Tamm, R Mägi, R Tremmel, et al.
Radiology|February 13, 2001
Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation ratesR J Jackman, F Burbank, S H Parker, et al.
Pharmacological Research|January 5, 2010
Enabling individualized therapy through nanotechnologyJason H Sakamoto, Anne L van de Ven, Biana Godin, et al.
Pageof 3